Distributing since 1889 • Employee Owned for Better Service
Your 1st Choice!
Sign In
Quick Search:
Cart
|
My Account
|
Print
Ordering
Advanced Search
Fast Order Entry
Express Order Entry
Can't Find Title?
Shopping Cart
Lists
New Receipts
Recall Information
Forthcoming Titles
Latest Price Changes
Downloads
About Us
Home Page
About Matthews
Return Policy
New Account Application
Publisher List
McCoy Medical
Med-Book
Contact Us
Job Opportunities
FAQ
Terms of Use
Product Detail
Behavioral Pharmacology of Neuropeptides: Oxytocin
Hurlemann, Rene
Pricing & Availability
Available: 0
List Price:$249.99
Email this title to a friend
Printer friendly version
Other formats:
E E Book + ProQuest Ebook Central
All Formats
Book Information
Edition:
1st
Publisher:
Springer Nature
ISBN:
3-319-63738-X (331963738X)
ISBN-13:
978-3-319-63738-9 (9783319637389)
Binding:
Hardcover
Copyright:
2017
Publish Date:
07/18
Weight:
0.00 Lbs.
Pages:
590
Subject Class:
NEU (Neurology and Neuroscience)
Return Policy:
Returns accepted up to 12 months provided no other recalls or return restrictions apply.
ProQuest Ebook Central:
Available in ProQuest Ebook Centralâ„¢
View
Class Specifications
Abstract:
This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry.The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of "precision medicine" approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews
Privacy Statement